Studies have shown that M2-sEVs transfer miRNA-221-3p to tumor cells to target CDKN1B, promote cell proliferation and G1/S conversion, and promote the progression of EOC (Li and Tang, 2020). The gene discussed is CDKN1B; the disease is neoplasm.